| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.44 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |